Cheri L. Coyle, M.D.

3.8 times the Medicare Part D claims of the average obstetrics & gynecology physician in 2024

627 Medicare Part D claims for 155 beneficiaries, against an average of 165 among the 28,733 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims. 11 claims were for opioids.

Most prescribed

1. Estradiol138 claims
2. Fluconazole31 claims
3. Valacyclovir30 claims
4. Ibandronate Sodium26 claims
5. Clobetasol Propionate24 claims
6. Alendronate Sodium22 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 83.8 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $433.28

19 payments; by number, the most common kind was food and beverage; the largest payer was Astellas Pharma US Inc. The 21,429 providers of this specialty with any payment received $1,030.61 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. Mid-Atlantic Womens Care PLCNewport News, VA
2. Uva Community Health Medical Group LLCCulpeper, VA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).